HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Controlled study of oxatomide vs disodium chromoglycate for treating adverse reactions to food.

Abstract
A controlled, cross-over trial was carried out to compare the efficacy and safety of oxatomide vs disodium chromoglycate (DSCG) for treating food allergy and intolerance. Twenty patients (15F, 5M; mean age 36.6 years), with chronic urticaria (twelve patients) or eczema (eight patients) caused by food allergy (ten cases) or food intolerance (ten cases), were treated with oxatomide (60 mg/day in a single evening administration) and with DSCG (2000 mg/day) for six weeks. The two treatments were separated by a 3-week wash-out period. All the patients completed the trial. During the treatment, both drugs succeeded in controlling the symptoms. With oxatomide, the wheals totally disappeared from 75% of the patients (p = 0.00135), the eczematous lesions disappeared from 64% (p = 0.056), and the itching from 70% (p = 0.00012); the figures for DSCG were 33%, 50% (p = 0.038) and 50%, respectively. Both drugs were well tolerated and there was no need to discontinue the treatment of any of the patients.
AuthorsM L Pacor, P Peroli, F Favari, C Lunardi
JournalDrugs under experimental and clinical research (Drugs Exp Clin Res) Vol. 18 Issue 3 Pg. 119-23 ( 1992) ISSN: 0378-6501 [Print] Switzerland
PMID1358563 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Piperazines
  • oxatomide
  • Cromolyn Sodium
Topics
  • Adolescent
  • Adult
  • Aged
  • Cromolyn Sodium (therapeutic use)
  • Double-Blind Method
  • Eczema (etiology)
  • Female
  • Food Hypersensitivity (drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Piperazines (therapeutic use)
  • Urticaria (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: